Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study.
Shi Y, Hu X, Li X, Gong C, Wang K, Li Y, Zhang S, Luo Y, Wang P, Jiang L, Meng X, Dong X, Wang H, Yang R, Mei Q, Liu B, Yang L, Sun Y.
Shi Y, et al. Among authors: li y, li x.
J Thorac Oncol. 2024 Jun;19(6):898-911. doi: 10.1016/j.jtho.2024.01.015. Epub 2024 Jan 29.
J Thorac Oncol. 2024.
PMID: 38295954
Clinical Trial.